Jonathan Paris - 24 Feb 2026 Form 4 Insider Report for Definitive Healthcare Corp. (DH)

Reporting relationship: Chief Legal Officer
Issuer ticker: DH
Reported as of: 24 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Feb 2026, 16:54:55 UTC
Prior SEC filing: 02 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Paris

Key filing fact

Jonathan Paris filed Form 4 for Definitive Healthcare Corp. (DH) on 26 Feb 2026.

Key facts

This page summarizes Jonathan Paris's Form 4 filing for Definitive Healthcare Corp. (DH).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 Feb 2026, 16:54.

Change

Previous filing in this sequence was filed on 02 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001866482 Primary reporting owner

Paris Jonathan

Relationship: Chief Legal Officer
Address: C/O DEFINITIVE HEALTHCARE CORP., 492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM
Signature: /s/ Jonathan Paris
Signature date: 26 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DH transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +481,505
Change %: +114%
Price: $0.000000
Shares after: 902,854
Date: 24 Feb 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Class A Common Stock, par value $0.001, with 25% of the RSUs vesting on March 1, 2027, followed by vesting of 6.25% every three months thereafter over the subsequent three years, subject to the Reporting Person's continued service with the Issuer through each such vesting date.